Radiation oncology firm Elekta posted a 3% decline in revenue after currency adjustment for its third quarter, which it attributed to supply chain challenges.
The company posted revenue of 3.6 billion Swedish krona ($382.8 million U.S.), a 3% decrease compared with the same period last year.
The company did see an 8% increase in orders compared to last year's third quarter, taking orders worth 4.4 billion krona ($468 million). The company is seeing a spike in orders from Europe, Egypt, and India, it said.
